Givlaari

Givosiran, sold under the brand name Givlaari, is a medication used for the treatment of adults with acute hepatic porphyria.[1][2][3][4] Givosiran is a small interfering RNA (siRNA) directed towards delta-aminolevulinate synthase 1 (ALAS1),[5] an important enzyme in the production of heme. The most common side effects include nausea and injection site reactions.[4] The U.S. Food and Drug Administr... [wikipedia]